These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10415751)

  • 1. Analytical aspects regarding the measurement of metalloproteinases.
    Lein M; Jung K; Nowak L; Schnorr D; Loening SA
    Ann N Y Acad Sci; 1999 Jun; 878():491-3. PubMed ID: 10415751
    [No Abstract]   [Full Text] [Related]  

  • 2. Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood.
    Jung K; Laube C; Lein M; Lichtinghagen R; Tschesche H; Schnorr D; Loening SA
    Clin Chem; 1998 May; 44(5):1060-2. PubMed ID: 9590387
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated plasma gelatinase A (MMP-2) activity is associated with quiescent Crohn's Disease.
    Kossakowska AE; Medlicott SA; Edwards DR; Guyn L; Stabbler AL; Sutherland LR; Urbanski SJ
    Ann N Y Acad Sci; 1999 Jun; 878():578-80. PubMed ID: 10415778
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer.
    Endo K; Maehara Y; Baba H; Yamamoto M; Tomisaki S; Watanabe A; Kakeji Y; Sugimachi K
    Anticancer Res; 1997; 17(3C):2253-8. PubMed ID: 9216697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
    Iizasa T; Fujisawa T; Suzuki M; Motohashi S; Yasufuku K; Yasukawa T; Baba M; Shiba M
    Clin Cancer Res; 1999 Jan; 5(1):149-53. PubMed ID: 9918213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum metalloproteinases and their inhibitors: markers for malignant potential.
    Baker T; Tickle S; Wasan H; Docherty A; Isenberg D; Waxman J
    Br J Cancer; 1994 Sep; 70(3):506-12. PubMed ID: 8080738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions.
    Gerlach RF; Meschiari CA; Marcaccini AM; Palei AC; Sandrim VC; Cavalli RC; Tanus-Santos JE
    Clin Chem Lab Med; 2009; 47(7):888-91. PubMed ID: 19575552
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection.
    Gohji K; Fujimoto N; Fujii A; Komiyama T; Okawa J; Nakajima M
    Cancer Res; 1996 Jul; 56(14):3196-8. PubMed ID: 8764105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of tissue inhibitor of metalloproteinases-2 and of precursor form of matrix metalloproteinase-2 in patients with liver disease.
    Ebata M; Fukuda Y; Nakano I; Katano Y; Fujimoto N; Hayakawa T
    Liver; 1997 Dec; 17(6):293-9. PubMed ID: 9455735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer.
    Gohji K; Fujimoto N; Ohkawa J; Fujii A; Nakajima M
    Br J Cancer; 1998 Feb; 77(4):650-5. PubMed ID: 9484825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of sequential serum measurements of gelatinases and tissue inhibitors during chemotherapy in ovarian cancer.
    Rauvala M; Turpeenniemi-Hujanen T; Puistola U
    Anticancer Res; 2006; 26(6C):4779-84. PubMed ID: 17214341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus Calmette-Guérin enhances production and secretion of type IV collagenases in peripheral blood mononuclear cells.
    Kageyama Y; Kawakami S; Fujii Y; Kihara K; Oshima H
    Jpn J Cancer Res; 1997 Mar; 88(3):281-8. PubMed ID: 9140113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloproteinases and tissue inhibitors of matrix-metalloproteinases in plasma of patients with prostate cancer and in prostate cancer tissue.
    Lein M; Nowak L; Jung K; Laube C; Ulbricht N; Schnorr D; Loening SA
    Ann N Y Acad Sci; 1999 Jun; 878():544-6. PubMed ID: 10415768
    [No Abstract]   [Full Text] [Related]  

  • 14. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia.
    Heo JH; Lucero J; Abumiya T; Koziol JA; Copeland BR; del Zoppo GJ
    J Cereb Blood Flow Metab; 1999 Jun; 19(6):624-33. PubMed ID: 10366192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.
    Rosell A; Alvarez-Sabín J; Arenillas JF; Rovira A; Delgado P; Fernández-Cadenas I; Penalba A; Molina CA; Montaner J
    Stroke; 2005 Jul; 36(7):1415-20. PubMed ID: 15947272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of gelatinases A and B to type I collagen yields both high and low affinity sites.
    Allan JA; Docherty AJ; Murphy G
    Ann N Y Acad Sci; 1994 Sep; 732():365-6. PubMed ID: 7978809
    [No Abstract]   [Full Text] [Related]  

  • 17. The in vivo effect of doxycycline treatment on matrix metalloproteinases in reactive arthritis.
    Lauhio A; Konttinen YT; Salo T; Tschesche H; Nordström D; Lähdevirta J; Golub LM; Sorsa T
    Ann N Y Acad Sci; 1994 Sep; 732():431-2. PubMed ID: 7978830
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies.
    Horstmann S; Kalb P; Koziol J; Gardner H; Wagner S
    Stroke; 2003 Sep; 34(9):2165-70. PubMed ID: 12907822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane.
    Fortunato SJ; Menon R; Lombardi SJ
    Am J Obstet Gynecol; 1997 Oct; 177(4):731-41. PubMed ID: 9369811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.